GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaidya Sane Ayurved Laboratories Ltd (NSE:MADHAVBAUG) » Definitions » Shares Outstanding (EOP)

Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Shares Outstanding (EOP) : 10.5 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Vaidyane Ayurved Laboratories Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Vaidyane Ayurved Laboratories's shares outstanding for the quarter that ended in Mar. 2024 was 10.5 Mil.

Vaidyane Ayurved Laboratories's quarterly shares outstanding declined from Sep. 2023 (12.6 Mil) to Mar. 2024 (10.5 Mil). It means Vaidyane Ayurved Laboratories bought back shares from Sep. 2023 to Mar. 2024 .

Vaidyane Ayurved Laboratories's annual shares outstanding stayed the same from Mar. 2023 (10.5 Mil) to Mar. 2024 (10.5 Mil).


Vaidyane Ayurved Laboratories Shares Outstanding (EOP) Historical Data

The historical data trend for Vaidyane Ayurved Laboratories's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaidyane Ayurved Laboratories Shares Outstanding (EOP) Chart

Vaidyane Ayurved Laboratories Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shares Outstanding (EOP)
Get a 7-Day Free Trial 10.51 10.51 10.51 10.51 10.51

Vaidyane Ayurved Laboratories Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only 10.51 10.51 10.51 12.64 10.51

Competitive Comparison of Vaidyane Ayurved Laboratories's Shares Outstanding (EOP)

For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaidyane Ayurved Laboratories's Shares Outstanding (EOP) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Vaidyane Ayurved Laboratories's Shares Outstanding (EOP) falls into.


;
;

Vaidyane Ayurved Laboratories Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Vaidyane Ayurved Laboratories  (NSE:MADHAVBAUG) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Vaidyane Ayurved Laboratories Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Vaidyane Ayurved Laboratories's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaidyane Ayurved Laboratories Business Description

Traded in Other Exchanges
N/A
Address
201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and therapies for treating chronic ailments. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management and knee pain relief. The company's business is divided into three segments i.e. Hospital Activity, Sale of Product and Common. It derives maximum revenue from Sale of Products.

Vaidyane Ayurved Laboratories Headlines

No Headlines